Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region

被引:17
作者
Hoshii, Yoshinobu [1 ]
Kiyama, Makiko
Cui, Dan
Kawano, Hiroo
Ishihara, Tokuhiro
机构
[1] Yamaguchi Univ, Sch Med, Dept Pathol 1, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Clin Neurosci, Ube, Yamaguchi 7558505, Japan
关键词
AL amyloidosis; immunoglobulin light chain variable region; immunohistochemistry;
D O I
10.1111/j.1440-1827.2006.01953.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To detect immunoglobulin (Ig) light chain amyloidosis (AL amyloidosis) in formalin-fixed, paraffin-embedded tissue sections by immunohistochemistry, polyclonal antibodies were generated against synthetic peptides corresponding to amino acids 1-19 of the Ig lambda light chain V lambda VI subgroup (anti-V lambda VI (1-19)) and the Ig kappa light chain V kappa I subgroup (anti-V kappa I (1-19)). Anti-V lambda VI (1-19) antibody reacted with amyloid deposits in 21 of 22 A lambda amyloidosis cases, and anti-V kappa I (1-19) antibody reacted with amyloid deposits in 10 of 11 A kappa amyloidosis cases. Immunoreactivity varied in intensity by case and within specimens. Surprisingly, amyloid deposits were positive for anti-V kappa I (1-19) staining in one case of A lambda amyloidosis. Analysis of anti-V lambda VI (1-19) and anti-V kappa I (1-19) antibody reactivity by ELISA showed some cross-reactivity with peptides other than antigen peptides. The antibodies were not reactive in all cases of AL amyloidosis examined but may be useful, together with anti-Ig constant region antibodies, for immunohistochemical diagnosis of AL amyloidosis.
引用
收藏
页码:324 / 330
页数:7
相关论文
共 24 条
[1]   PRODUCTION AND IMMUNODIAGNOSTIC APPLICATIONS OF ANTIHUMAN LIGHT-CHAIN MONOCLONAL-ANTIBODIES [J].
ABE, M ;
GOTO, T ;
KENNEL, SJ ;
WOLFENBARGER, D ;
MACY, SD ;
WEISS, DT ;
SOLOMON, A .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (01) :67-74
[2]   Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL) [J].
Abraham, RS ;
Geyer, SM ;
Price-Troska, TL ;
Allmer, C ;
Kyle, RA ;
Gertz, MA ;
Fonseca, R .
BLOOD, 2003, 101 (10) :3801-3808
[3]   MECHANISMS OF DISEASE - MONOCLONAL IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASE [J].
BUXBAUM, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :323-346
[4]   Immunoglobulin lambda light chains are the precursors of ureteral localized amyloidosis:: a micromethod for extraction of amyloid [J].
Castaño, EM ;
Prelli, F ;
Morelli, L ;
Avagnina, A ;
Kahn, A ;
Frangione, B .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1997, 4 (04) :253-258
[5]   The tropism of organ involvement in primary systemic amyloidosis:: contributions of Ig VL germ line gene use and clonal plasma cell burden [J].
Comenzo, RL ;
Zhang, Y ;
Martinez, C ;
Osman, K ;
Herrera, GA .
BLOOD, 2001, 98 (03) :714-720
[6]   AMYLOID FIBRILS DERIVED FROM V-REGION TOGETHER WITH C-REGION FRAGMENTS FROM A LAMBDA-II-IMMUNOGLOBULIN LIGHT CHAIN (HAR) [J].
EULITZ, M ;
LINKE, R .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1985, 366 (09) :907-915
[7]  
HOSHII Y, 1994, PATHOL INT, V44, P352
[8]   Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis [J].
Hoshii, Y ;
Setoguchi, M ;
Iwata, T ;
Ueda, J ;
Cui, D ;
Kawano, H ;
Gondo, T ;
Takahashi, M ;
Ishihara, T .
PATHOLOGY INTERNATIONAL, 2001, 51 (04) :264-270
[9]  
Imada N, 1981, YAMAGUCHI MED J, V30, P149
[10]  
ISERSKY C, 1972, J IMMUNOL, V108, P486